These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The prognostic impact of pre-implantation hyponatremia on morbidity and mortality among patients with left ventricular dysfunction and implantable cardioverter-defibrillators. Bhavnani SP; Kumar A; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J Europace; 2014 Jan; 16(1):47-54. PubMed ID: 23954920 [TBL] [Abstract][Full Text] [Related]
23. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy. Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186 [TBL] [Abstract][Full Text] [Related]
24. Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment. van der Heijden AC; Höke U; Thijssen J; Borleffs CJ; van Rees JB; van der Velde ET; Schalij MJ; van Erven L Eur J Heart Fail; 2014 Oct; 16(10):1104-11. PubMed ID: 25138313 [TBL] [Abstract][Full Text] [Related]
26. Atrial support pacing in heart failure: results from the multicenter PEGASUS CRT trial. Martin DO; Day JD; Lai PY; Murphy AL; Nayak HM; Villareal RP; Weiner S; Kraus SM; Stolen KQ; Gold MR J Cardiovasc Electrophysiol; 2012 Dec; 23(12):1317-25. PubMed ID: 22830441 [TBL] [Abstract][Full Text] [Related]
27. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF. Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311 [TBL] [Abstract][Full Text] [Related]
28. Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction. Biton Y; Goldenberg I; Kutyifa V; Baman JR; Solomon S; Moss AJ; Szepietowska B; McNitt S; Polonsky B; Zareba W; Barsheshet A J Am Coll Cardiol; 2016 Jan; 67(3):303-12. PubMed ID: 26796396 [TBL] [Abstract][Full Text] [Related]
29. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry. Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A; Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128 [TBL] [Abstract][Full Text] [Related]
30. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C; J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193 [TBL] [Abstract][Full Text] [Related]
31. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
32. Right ventricular septal pacing as alternative for failed left ventricular lead implantation in cardiac resynchronization therapy candidates. Alhous MH; Small GR; Hannah A; Hillis GS; Frenneaux M; Broadhurst PA Europace; 2015 Jan; 17(1):94-100. PubMed ID: 25359384 [TBL] [Abstract][Full Text] [Related]
33. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Barsheshet A; Goldenberg I; Moss AJ; Eldar M; Huang DT; McNitt S; Klein HU; Hall WJ; Brown MW; Goldberger JJ; Goldstein RE; Schuger C; Zareba W; Daubert JP Eur Heart J; 2011 Jul; 32(13):1622-30. PubMed ID: 21075774 [TBL] [Abstract][Full Text] [Related]
34. Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy. Kronborg MB; Albertsen AE; Nielsen JC; Mortensen PT Europace; 2009 Sep; 11(9):1177-82. PubMed ID: 19661114 [TBL] [Abstract][Full Text] [Related]
38. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy. Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892 [TBL] [Abstract][Full Text] [Related]
39. Impact of cardiac resynchronization therapy-defibrillator implantation on the association between body mass index and prognosis in patients with heart failure. Yanagisawa S; Inden Y; Shimano M; Yoshida N; Ishikawa S; Kato H; Okumura S; Miyoshi-Fujii A; Nagao T; Yamamoto T; Mizutani Y; Ito T; Hirai M; Murohara T J Interv Card Electrophysiol; 2015 Sep; 43(3):269-77. PubMed ID: 26003807 [TBL] [Abstract][Full Text] [Related]
40. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy. Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]